NAALADL2

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA012413

Antibody HPA017425

Antibody CAB025586

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A variable staining intensity was observed among each malignancy. Prostate, breast, liver, pancreatic, colorectal, endometrial and urothelial cancers showed moderate to strong cytoplasmic positivity. Malignant gliomas, melanoma and lymphomas as well as renal, gastric and skin cancers were weakly stained or negative. Prostate and endometrial cancers showed moderate to strong cytoplasmic immunoreactivity. Several cases of colorectal, breast, ovarian, lung, urothelial and pancreatic cancers showed moderate positivity. Remaining malignant cells generally showed weak staining or were negative.Prostate cancers exhibited moderate to strong cytoplasmic immunoreactivity. Remaining malignant cells were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected